Democrats Demand Answers After White House Denies Trump Received Experimental Weight Loss Drug
Key takeaways
- Hassan sent a letter to Health and Human Services Secretary Robert F.
- The report from Tuesday noted a 79-year-old man was given an Eli Lilly weight loss drug not yet approved by the FDA following a request made in April, when Trump was still 79 years old.
- The White House aggressively denied the STAT News report, saying Trump was not the person who received the drug and calling the STAT reporter a “big idiot.”
Topline Democrats pressed the White House for answers this week after it denied a STAT News report suggesting President Donald Trump may have received access to an experimental weight loss drug under the Food and Drug Administration’s “compassionate use” program, which is often reserved for patients with life-threatening conditions.
Hassan sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday. (Photo by Andrew Harnik/Getty Images)Getty Images Key Facts Sen. Maggie Hassan, D-N.H., said in a Wednesday letter addressed to Health and Human Services Secretary Robert F. Kennedy Jr. that she was “deeply concerned” by reports that suggested he “may be bending the rules of a federal program, and exerting improper political pressure, in order to provide a well-connected individual with free access to an exclusive prescription drug.”
The report from Tuesday noted a 79-year-old man was given an Eli Lilly weight loss drug not yet approved by the FDA following a request made in April, when Trump was still 79 years old.